Back

Impact of lipoprotein(a) concentrations on atherosclerotic cardiovascular disease onset: a survival analysis

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Lipoprotein(a) (1) Lipids Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Viviane Zorzanelli Rocha

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
Combined effects of lipoprotein(a) and HDL cholesterol on cardiovascular mortality: a longitudinal study
Professor B. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
High lipoprotein(a) and high BMI jointly confer the highest risk of ASCVD in both primary and secondary prevention
Mr P. Thomas (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Extra-virgin olive oil intake and lipoprotein A levels in the PREDIMED-Plus study
Doctor J. Diaz-Gutierrez (Huelva, ES)
Abstract Slides Video
Presentation thumbnail
Lipoprotein(a), high-sensitive c reactive protein, and long-term survival after coronary artery bypass grafting
Doctor S. Yuan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Patient views on lipoprotein (a) testing and treatment for secondary prevention of cardiovascular disease - results from 7 countries across 6 WHO regions from the INTERASPIRE study
Professor C. Jennings (Galway, IE)
Abstract Slides

Access the full session

Session thumbnail
Lipoprotein(a) (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) and atherosclerotic cardiovascular disease in a Brazilian tertiary hospital population
thumbnail
Congress Presentation
Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database
thumbnail
Congress Presentation
Association of elevated lipoprotein(a) with future major adverse cardiovascular events in recurrent ASCVD patients: analysis of a large US electronic health record database

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources